Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcohol effects, a new study suggests. Studies have shown that people report decreased alcohol consumption when taking glucagon-like peptide-1 receptor (GLP-1) agonists. Patients taking semaglutide (such as Ozempic and Wegovy) showed a 36% lower risk of alcohol-related hospitalization, and those taking liraglutide (Victoza) had a 28% lower risk. Advertisement AdvertisementFor more Health articles, visit www.foxnews.com/healthFox News Digital reached out to the study researchers and also to Eli Lilly, maker of Retatrutide, requesting comment. Original article source: Diabetes and weight loss drugs shown to reduce alcohol-related hospitalizations, study finds

Source: Fox News November 18, 2024 07:06 UTC